AI assistant
CVS HEALTH Corp — Director's Dealing 2017
Sep 19, 2017
29875_dirs_2017-09-19_8ad8e2f5-f678-4243-9332-c4bf7a15bdb8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2017-09-18
Reporting Person: Roberts Jonathan C (EVP & Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-18 | Common Stock | M | 85743 | $34.96 | Acquired | 119555.1293 | Direct |
| 2017-09-18 | Common Stock | S | 85743 | $83.14 | Disposed | 33812.1293 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-18 | Stock Option | $34.96 | M | 85743 | Disposed | 2018-04-01 | Common Stock (85743) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (restricted) | 70780 | Direct |
| ESOP Common Stock | 5319.994 | Indirect |
| Stock Unit | 154874.2001 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Stock Credits | $1.00 | Common Stock (1418.9113) | 1418.9113 | Direct | |
| Stock Option | $45.07 | 2019-04-02 | Common Stock (77639) | 77639 | Direct |
| Stock Option | $54.53 | 2020-04-01 | Common Stock (68844) | 68844 | Direct |
| Stock Option | $74.29 | 2021-04-01 | Common Stock (73433) | 73433 | Direct |
| Stock Option | $45.93 | 2022-09-04 | Common Stock (108870) | 108870 | Direct |
| Stock Option | $102.26 | 2022-04-01 | Common Stock (68482) | 68482 | Direct |
| Stock Option | $104.82 | 2023-04-01 | Common Stock (161318) | 161318 | Direct |
| Stock Option | $78.05 | 2024-04-03 | Common Stock (200358) | 200358 | Direct |
Footnotes
F1: All sales were effected pursuant to a Rule 10b5-1 plan.
F2: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $82.89 and $83.35 per share.
F3: Option became exercisable in four equal annual installments, commencing 4/1/2012.
F4: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F5: Option became exercisable in four equal annual installments, commencing 4/2/2013.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2014.
F7: Option became exercisable in four equal annual installments, commencing 4/1/2015.
F8: Option became exercisable in three equal annual installments, commencing 9/4/2015.
F9: Option became exercisable in four equal annual installments, commencing 4/1/2016.
F10: Option became exercisable in four equal annual installments, commencing 4/1/2017.
F11: Option becomes exercisable in four equal annual installments, commencing 4/3/2018.